Synthesis and investigation of antimicrobial activity of some bisbenzimidazole-derived chelating agents

European Journal of Medicinal Chemistry

Volumn 38, Issue 10, 2003, Pages 875-881

  Agh Atabay, Naz M ^a   Dulger, Basaran ^b   Gucin, Fahrettin ^a  

^a FATIH UNIVERSITY   (Turkey)

^b ÇANAKKALE ONSEKIZ MART UNIVERSITY   (Turkey)

Author keywords

Ampicillin; Bisbenzimidazole; Chelating ligands; Equipotent; Ofloxacin

Indexed keywords

1,2 BIS(2 BENZIMIDAZYL) 1,2 ETHANEDIOL; 1,3 BIS(2 BENZIMIDAZYL) 2 THIAPROPANE; 1,4 BIS(2 BENZIMIDAZYL) 1,2,3,4 BUTANETETRAOL; 1,5 BIS(2 BENZIMIDAZYL) 3 THIAPENTANE; AMPHOTERICIN B; AMPICILLIN; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; BENZIMIDAZOLE DERIVATIVE; CEFAZOLIN; CHELATING AGENT; CIPROFLOXACIN; FLUCONAZOLE; FLUCYTOSINE; LIGAND; OFLOXACIN; PIPERACILLIN; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIFUNGAL ACTIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CANDIDA ALBICANS; CANDIDA UTILIS; CARBON NUCLEAR MAGNETIC RESONANCE; CONTROLLED STUDY; CRYPTOCOCCUS NEOFORMANS; DATA ANALYSIS; DRUG ACTIVITY; DRUG POTENCY; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; INFRARED SPECTROSCOPY; NONHUMAN; PROTON NUCLEAR MAGNETIC RESONANCE; RAMAN SPECTROMETRY; SPECTROMETER; SPECTROSCOPY;

EID: 0142250757     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(03)00146-6     Document Type: Article

References (21)

1. Groziak M.P., Huan Z.-W., Ding H., Meng Z., Stevens W.C., Robinson P.D. J. Med. Chem. 40:1997;3336-3345.
2. Szyszka R., Grandkowski N., Felezak K., Shugar D. Biochem. Biophys. Res. Commun. 208:1995;418-424.
3. Saluja S., Zou R., Drach J.C., Townsend L.B. J. Med. Chem. 39:1996;881-891.
4. Zou R., Ayres K.R., Drach J.C., Townsend L.B. J. Med. Chem. 39:1996;3477-3482.
5. Pratt W.B. Chemotherapy of Infection. 1977;Oxford University Press, New York.
6. Demir A.S., Hamamci H., Sesenoglu O., Neslihanoglu R., Asikoglu B., Capanoglu D. Tetrahedron Lett. 43:2002;6447-6449.
7. Çakir B., Büyükbigöl E., Uçucu Ü., Abbasoôlu U., Noyanalpan N. J. Fac. Pharm. Gazi. 71:1988;71-77.
8. S. Akihama, K. Takahashi and N. Miyajama, Yakogaku Zasshi, 94, 247 (1974). CA 81: 9648.
9. S. Akihama, K. Takahashi and N. Miyajama, Yakogaku Zasshi, 94, 247 (1974). CA 81: 9648.
10. Schendel F.J., Cheng Y.S., Otvos J.D., Wehrli S., Stubbe J. Biochemistry. 27:1988;2614-2623.
11. Castilo-Blum S.E., Barba-Behrens N. Coordination Chem. Rev. 196:2000;3-30.
12. Sing P., Sing S.P. Plant Physiol. 83:1987;12.
13. Tavman A., Ülküseven B., Agh-Atabay N.M. Transition Metal Chem. 25:2000;324-328.
14. Sunberg J., Martin R.B. Chem. Rev. 74:1974;471.
15. Ali M.A., Mirza A.H., Nazimuddin M., Dhar P.K., Butcher R.J. Transition Metal Chem. 27:2002;27-33.
16. M.A. Philips, J. Chem. Soc. (1931) 1143.
17. Addison A.W., Burke P.J. Heterocyclic Chem. 18:1981;803-805.
18. Mc Cutcheon A.R., Ellis S.M., Hancock R.E.W., Towers G.H.N. J. Ethnopharmacol. 37:1992;213-223.
19. National Committee for Clinical Laboratory Standards, Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 4th ed. Approved standard (M7-A4). National Committee for Clinical Laboratory Standards, Wayne, PA, 1997.
20. National Committee for Clinical Laboratory Standards, Methods for determining bactericidal activity of antimicrobial agents. Proposed guideline (M26-P). National Committee for Clinical Laboratory Standards, Villonova, PA, 1987.
21. National Committee for Clinical Laboratory Standards, Reference method for broth dilution antifungal susceptibility testing of yeasts. Tentative standard (M27-T). National Committee for Clinical Laboratory Standards, Wayne, PA, 1995.